GETSET trial

The GETSET trial (short for Graded Exercise Therapy Guided Self-Help Trial for Patients with Chronic Fatigue Syndrome) was a trial investigating the effectiveness of "guided graded exercise self-help" in patients with CFS/ME. The protocol was published in June 2016. The results were published in June 2017.

Researchers
Lead Author Lucy Clark, Peter White, Francesca Pesola, Janice M Thomas,  Mario Vergara-Williamson and Michelle Beynon

Funding
The trial was funded in full by the National Institute for Health Research's Research for Patient Benefit programme.

Protocol
The protocol of the trial was published in JMIR Research Protocols in June 2016.

Publication
The results were published on 22 June 2017 in the Lancet 'Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial'

Commentary was provided by Daniel Clauw in the Lancet Guided graded exercise self-help as a treatment of fatigue in chronic fatigue syndrome.

The Science Media Centre provided  Expert reaction to study on guided self-help graded exercise therapy as a treatment for chronic fatigue syndrome (CFS).

It was reported in the Telegraph as Exercise can help chronic fatigue syndrome, study shows and other media outlets Defeating chronic fatigue thanks to guided self-help approach to exercise.

Criticism
Dr David Tuller has criticised the trial Trial by Error, Continued: More on Graded Exercise from Peter White and The Lancet.

Spoonseekerdotcom has criticised the GETSET trial.

Professor Jonathan Edwards criticised the study for its "incompetent level of science".

The ME Association has also criticised the trial ME Association Review: GETSET fails to demonstrate GET can significantly improve physical function.

Additional criticism has been published by other patients.

Documents

 * Lead author Lucy Clark had previously published a booklet called Graded Exercise Therapy - A self-help guide for those with chronic fatigue syndrome/myalgic encephalomyelitis. This booklet was apparently distributed to patients in the GETSET trial.